No FDA-cleared AST platforms meet clinical labs’ requirement for same-shift results. SeLux’s rapid method takes only 4 hours, uniquely enabling same-day changes in patient treatment.
SeLux’s USA reagent detects the presence of bacteria hours before standard methods.
The SeLux USA works across a broad menu of bacteria, delivering flexibility and breadth to labs.
The SeLux process is compatible with standard microplates and signal detectors, making adoption easy.
One SeLux system delivers 50 AST tests per day, exceeding the workflow needs of labs.
The SeLux system leverages standard microbiology processes so labs can easily integrate SeLux technology while increasing efficiency.
Menu of 60+ antibiotics and easy incorporation of newly-approved drugs.
CTO & Co-founder
Aleksandar Vacic is the President and co-founder of SeLux. His primary leadership role at SeLux is engineering and product development. As an applied physicist and electrical engineer, Alek believes that both strong theoretical foundations and hands-on practical insights must be exploited to commercialize novel technologies. He enjoys working with multidisciplinary teams solving complex problems. His work has spanned semiconductors, plasma engineering, optics, optoelectronics, bioelectronics, Monte Carlo simulations, and numerical algorithms.
Previously, he led the Cell Processing team at 1366 Technologies where he transferred processes to customer manufacturing sites in Asia and Europe, and developed a plasma texturing process for high efficiency solar cells.
While at Yale he developed fabrication and design methods to improve yield and reliability of nanoscale biosensors including the understanding of semiconductor-biomolecule interaction which resulted in a novel calibration and quantification methodology. He has 2 granted, 1 licensed, and 10 pending patents and provisional applications. He earned his PhD from Yale and Dipl.-Ing. (5 year) in Technical Physics from the School of Electrical Engineering in Belgrade (Serbia) as Valedictorian (Class of 600+). While at Yale he was awarded the Best Presentation award at the Nanodevices for Defense and Security Conference 2009 and Yale College Prize Teaching Fellowship. When not solving difficult problems, Alek enjoys travelling, cooking and running with his awesome spouse, Yi-Wen.
President & Co-founder
As the Principal Software Developer, Derek is responsible for the design and implementation of the software architecture for the SeLux Diagnostics AST platform. <\P>
Derek has over 20 years of experience in the medical imaging, biotech, and immunotherapy industries. Prior to joining SeLux Diagnostics, he was Principal Software Developer at the Waltham site for Juno Therapeutics, a Seattle-based immunotherapy company. At Juno, he built a suite of data storage, processing, and analysis tools to enable identification of lead candidates in the Juno antibody discovery platform. Previously, Derek was Director of Software Engineering at SRU Biosystems, where he developed data acquisition and analysis capabilities for their label-free detection platform for small molecule and protein binding assays. He began his career with Picker Medical Systems (now Philips Healthcare), working on visualization of dose distributions for their AcQSim™ radiation therapy treatment planning software.
Principal Software Engineer
We founded SeLux in 2014 after a successful technical demonstration done in partnership with a Harvard clinic. We are very thankful to all our investors for giving us the opportunity to change the field of diagnostics. We have built our core team and are always looking for scientific and engineering talent.
SeLux Diagnostics, Inc
480 Arsenal Street (Way), Bldg.1 Fl. 2
Watertown, MA 02472
Info [AT] SeLuxDX [.] com